Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Study of Sublingual Minoxidil in Healthy Volunteers
NCT06679556Phase 1Completed
- Sponsor
- Samson Clinical
- Start
- Nov 2024
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of minoxidil in androgenetic alopecia (AGA) (2 arms), sponsored by Samson Clinical. Primary endpoints: Area under the concentration-time profile from time zero to the last measurable concentration at Day 8, Area under the concentration-time profile from time zero to infinity at Day 8 and 4 more. Started Nov 2024; status: completed.
02
Drugs
minoxidil
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on NCT06679556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06679556.